Extrahepatic manifestations of hepatitis C virus infection in the oral cavity

According to data from the World Health Organization (WHO), the number of people actively infected with hepatitis C virus (HCV) in the world currently reaches 50 million.In the last few years, there has been a revolution in the treatment of chronic hepatitis C (CHC) and now safe interferon-free regimens based on drugs with direct-acting antivirals (DAA) are available in the treatment of HCV infections, the effectiveness of which exceeds 95%.As a result, according to WHO forecasts, it is possible to eliminate HCV infection by 2030.A necessary condition to achieve this goal is the diagnosis of the disease in patients unaware of the infection.Chronic HCV infection can lead to extrahepatic manifestations, including changes in the oral mucosa such as xerostomia, lichen planus, or periodontal diseases.The aim of this publication is to draw attention to the extrahepatic symptoms with which a patient infected with HCV may present to a dentist.

Authors

Publication Details

Journal
Medical Studies
Published
2025-01-01
DOI
https://doi.org/10.5114/ms.2025.154759
Primary Topic
Parvovirus B19 Infection Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extrahepatic manifestations of hepatitis C virus infection in the oral cavity

Krystyna Dobrowolska, Michał Brzdęk, Piotr M. Stępień, Magdalena Kal et al.
Medical Studies
Parvovirus B19 Infection Studies
article

Extrahepatic manifestations of hepatitis C virus infection in the oral cavity

Krystyna Dobrowolska, Michał Brzdęk, Piotr M. Stępień, Magdalena Kal, Dorota Zarębska‐Michaluk, Kinga Brzdęk, Joanna Gałuszka-Garnuszek
article en

Abstract

According to data from the World Health Organization (WHO), the number of people actively infected with hepatitis C virus (HCV) in the world currently reaches 50 million.In the last few years, there has been a revolution in the treatment of chronic hepatitis C (CHC) and now safe interferon-free regimens based on drugs with direct-acting antivirals (DAA) are available in the treatment of HCV infections, the effectiveness of which exceeds 95%.As a result, according to WHO forecasts, it is possible to eliminate HCV infection by 2030.A necessary condition to achieve this goal is the diagnosis of the disease in patients unaware of the infection.Chronic HCV infection can lead to extrahepatic manifestations, including changes in the oral mucosa such as xerostomia, lichen planus, or periodontal diseases.The aim of this publication is to draw attention to the extrahepatic symptoms with which a patient infected with HCV may present to a dentist.

Medical StudiesVol. 41(3)
Uniwersytet Jana Kochanowskiego w Kielcach
Openalex Percentile: Top 64%
Parvovirus B19 Infection Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Extrahepatic manifestations of hepatitis C virus infection in the oral cavity — Krystyna Dobrowolska, Michał Brzdęk, et al. · Medical Studies (2025) | TGRS Research Map | TGRS